Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNuformix Regulatory News (NFX)

Share Price Information for Nuformix (NFX)

Share Price is delayed by 15 minutes
Get Live Data
0.18    0.0165 (9.79%)
Bid:
0.17
Ask:
0.19
Spread: 0.02 (11.765%)
Market Cap: £4.83m
NFX Live PriceLast checked at - London Stock Exchange

Intraday Nuformix Share Chart

New Accounting Ref Date

21 Sep 2016 07:00

RNS Number : 3814K
Levrett PLC
21 September 2016
 

 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR IN OR INTO, AUSTRALIA, CANADA, JAPAN, THE UNITED STATES OF AMERICA OR SOUTH AFRICA OR ANY JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.

 

 

Levrett Plc

("Levrett" or "the Company")

 

Change of accounting reference date

  

Levrett announces that the Board has approved a change in its accounting reference date from 31 December to 31 March, effective from 31 March 2016. 

 

 

Enquiries:

Levrett Plc

Pascal Hughes, CEO

 

+44 (0) 20 7183 4342

 

 

Whitman Howard Limited

Niall Baird / Nick Lovering

 

+44 (0) 20 7659 1234

Gable Communications Limited

John Bick

+44 (0) 20 7193 7463

+44 (0) 7872 061007

 

levrett@gablecommunications.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NARLLFVAAVIIFIR
Date   Source Headline
12th Nov 20217:00 amRNSNXP004 patent application filing
9th Nov 20217:00 amRNSDirectorate Change
4th Oct 20212:01 pmRNSPrice Monitoring Extension
16th Sep 20212:14 pmRNSDirector/PDMR Shareholding - Replacement
16th Sep 202112:47 pmRNSDirector/PDMR Shareholding
13th Sep 20217:00 amRNSLicensing agreement with Oxilio for NXP001
24th Aug 202111:57 amRNSResult of AGM
23rd Jul 20211:35 pmRNSPosting of Annual Report and Notice of AGM
22nd Jul 20217:00 amRNSLetter to shareholders re: Dr Anne Brindley
21st Jul 20214:41 pmRNSSecond Price Monitoring Extn
21st Jul 20214:36 pmRNSPrice Monitoring Extension
21st Jul 20217:00 amRNSDirectorate Change
15th Jul 20217:00 amRNSFinal results for the year ended 31 March 2021
10th Jun 20219:25 amRNSHolding(s) in Company
7th Jun 20217:00 amRNSNotice of Allowance of Patent in US
1st Jun 20217:00 amRNSProject update - Progress on NXP002 and NXP004
24th May 20217:00 amRNSDirectorate Changes
12th May 202111:35 amRNSHolding(s) in Company
11th May 20211:51 pmRNSHolding(s) in Company
22nd Apr 20212:06 pmRNSSecond Price Monitoring Extn
22nd Apr 20212:00 pmRNSPrice Monitoring Extension
8th Apr 20213:30 pmRNSCorrection: Holding(s) in Company
8th Apr 202111:54 amRNSHolding(s) in Company
6th Apr 202110:38 amRNSHolding(s) in Company
30th Mar 20215:14 pmRNSHolding(s) in Company
29th Mar 202111:27 amRNSResult of General Meeting and Total Voting Rights
22nd Mar 20217:00 amRNSNXP001 (Oncology) - Exercise of Option by Oxilio
19th Mar 20214:41 pmRNSSecond Price Monitoring Extn
19th Mar 20214:36 pmRNSPrice Monitoring Extension
19th Mar 202111:05 amRNSSecond Price Monitoring Extn
19th Mar 202111:00 amRNSPrice Monitoring Extension
19th Mar 20219:05 amRNSSecond Price Monitoring Extn
19th Mar 20219:00 amRNSPrice Monitoring Extension
11th Mar 20217:00 amRNSInitiation of research by Allenby Capital
10th Mar 202111:05 amRNSSecond Price Monitoring Extn
10th Mar 202111:00 amRNSPrice Monitoring Extension
10th Mar 20219:05 amRNSSecond Price Monitoring Extn
10th Mar 20219:00 amRNSPrice Monitoring Extension
10th Mar 20217:00 amRNSProposed Placing to raise £1.565 million
8th Mar 202112:00 pmRNSHolding(s) in Company
2nd Mar 20217:00 amRNSResearch Results
22nd Feb 20213:45 pmRNSHolding(s) in Company
10th Feb 20217:00 amRNSDirectorate Change
2nd Feb 20212:06 pmRNSSecond Price Monitoring Extn
2nd Feb 20212:01 pmRNSPrice Monitoring Extension
22nd Dec 20207:00 amRNSAppointment of Broker
22nd Dec 20207:00 amRNSHalf-year Report
7th Dec 20207:00 amRNSAppointment of Chief Executive Officer
2nd Dec 20207:00 amRNSAppointment of Non-Executive Director
24th Nov 20207:00 amRNSAppointment of Non-Executive Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.